Applied DNA Sciences, Inc. (APDN)

USD 0.92

(-20.34%)

Revenue Summary of Applied DNA Sciences, Inc.

  • Applied DNA Sciences, Inc.'s latest annual revenue in 2023 was 13.36 Million USD , down -26.43% from previous year.
  • Applied DNA Sciences, Inc.'s latest quarterly revenue in 2024 Q2 was 929.63 Thousand USD , up 4.32% from previous quarter.
  • Applied DNA Sciences, Inc. reported a annual revenue of 18.16 Million USD in annual revenue 2022, up 101.25% from previous year.
  • Applied DNA Sciences, Inc. reported a annual revenue of 9.02 Million USD in annual revenue 2021, up 367.4% from previous year.
  • Applied DNA Sciences, Inc. reported a quarterly revenue of 891.16 Thousand USD for 2024 Q1, up 14.29% from previous quarter.
  • Applied DNA Sciences, Inc. reported a quarterly revenue of 797.51 Thousand USD for 2024 Q3, down -14.21% from previous quarter.

Annual Revenue Chart of Applied DNA Sciences, Inc. (2023 - 1998)

Historical Annual Revenue of Applied DNA Sciences, Inc. (2023 - 1998)

Year Revenue Revenue Growth
2023 13.36 Million USD -26.43%
2022 18.16 Million USD 101.25%
2021 9.02 Million USD 367.4%
2020 1.93 Million USD -64.16%
2019 5.38 Million USD 38.06%
2018 3.9 Million USD -17.85%
2017 4.75 Million USD 13.49%
2016 4.18 Million USD -53.53%
2015 9 Million USD 231.05%
2014 2.72 Million USD 33.64%
2013 2.03 Million USD 9.79%
2012 1.85 Million USD 91.43%
2011 968.84 Thousand USD 86.37%
2010 519.84 Thousand USD 76.12%
2009 295.16 Thousand USD -66.19%
2008 873.01 Thousand USD 616.05%
2007 121.92 Thousand USD 545.08%
2006 18.9 Thousand USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%

Peer Revenue Comparison of Applied DNA Sciences, Inc.

Name Revenue Revenue Difference
Aspira Women's Health Inc. 9.15 Million USD -46.028%
bioAffinity Technologies, Inc. 2.53 Million USD -427.836%
Intelligent Bio Solutions Inc. 3.11 Million USD -329.575%
Standard BioTools Inc. 106.34 Million USD 87.43%
Inotiv, Inc. 572.42 Million USD 97.665%
Prenetics Global Limited 21.74 Million USD 38.52%
Neuronetics, Inc. 71.34 Million USD 81.264%
Star Equity Holdings, Inc. 45.78 Million USD 70.804%
Castle Biosciences, Inc. 219.78 Million USD 93.918%
Psychemedics Corporation 22.09 Million USD 39.508%
RadNet, Inc. 1.61 Billion USD 99.173%
Exact Sciences Corporation 2.49 Billion USD 99.465%
IDEXX Laboratories, Inc. 3.66 Billion USD 99.635%
iSpecimen Inc. 9.92 Million USD -34.641%
OpGen, Inc. 3.41 Million USD -291.053%
Exagen Inc. 52.54 Million USD 74.561%
Bionano Genomics, Inc. 36.11 Million USD 62.987%
CareDx, Inc 280.32 Million USD 95.231%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 95.729%
Guardant Health, Inc. 563.94 Million USD 97.63%
Biodesix, Inc. 49.08 Million USD 72.768%
BioNexus Gene Lab Corp. 9.77 Million USD -36.81%
Precipio, Inc. 15.19 Million USD 12.039%
Natera, Inc. 1.08 Billion USD 98.765%
Fulgent Genetics, Inc. 289.21 Million USD 95.378%
Sera Prognostics, Inc. 306 Thousand USD -4268.445%
23andMe Holding Co. 219.63 Million USD 93.914%
OPKO Health, Inc. 863.49 Million USD 98.452%
Personalis, Inc. 73.48 Million USD 81.808%
Aclaris Therapeutics, Inc. 31.24 Million USD 57.223%
T2 Biosystems, Inc. 7.19 Million USD -85.84%
Neogen Corporation 924.22 Million USD 98.554%
Myriad Genetics, Inc. 678.4 Million USD 98.03%
ICON Public Limited Company 8.12 Billion USD 99.835%
NeoGenomics, Inc. 591.64 Million USD 97.741%
Star Equity Holdings, Inc. 45.78 Million USD 70.804%
MDxHealth SA 70.19 Million USD 80.956%
Prenetics Global Limited 21.74 Million USD 38.52%
Illumina, Inc. 4.5 Billion USD 99.703%
DarioHealth Corp. 20.35 Million USD 34.319%
ENDRA Life Sciences Inc. - USD -Infinity%
Medpace Holdings, Inc. 1.88 Billion USD 99.291%
Mainz Biomed B.V. 895.47 Thousand USD -1392.77%
Trinity Biotech plc 56.83 Million USD 76.479%
Sotera Health Company 1.04 Billion USD 98.726%
bioAffinity Technologies, Inc. 2.53 Million USD -427.836%